Cargando…
Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis
BACKGROUND: To assess the efficacy and safety of anaplastic lymphoma kinase inhibitors (ALKIs) for the treatment of advanced‐stage ALK rearrangement‐positive non–small cell lung cancer (NSCLC). METHODS: We searched PubMed, EMBASE, and the Cochrane Library for randomized controlled trials (RCTs) that...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067357/ https://www.ncbi.nlm.nih.gov/pubmed/36908264 http://dx.doi.org/10.1111/1759-7714.14824 |